News LEO Pharma's Adtralza approved by MHRA, EC for adolescent at... The Medicines and Healthcare products Regulatory Agency (MHRA) and the European Commission (EC) have
News NICE changes stance on Genmab's cervical cancer drug After saying it couldn't recommend Genmab's cervical cancer therapy Tivdak for use by the NHS, reimbursement authority NICE has had a change of heart.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
